“…A second potential step to target in the caspase-3 apoptotic cascade involves the events that are upstream of caspase-3, but downstream of the cytochrome c release, in particular the family of inhibitor of apoptosis proteins Duckett et al, 1998;Ekert et al, 1999;Ekert et al, 2001). The first identified IAP family member was p35, a baculoviral protein that suppresses apoptosis in a number of cell types (including cells of the CNS) and under a variety of conditions (Rabizadeh et al, 1993;Simons et al, 1999;Xu et al, 1999;Eberhardt et al, 2000;Hisahara et al, 2000;Kugler et al, 2000;Korhonen et al, 2001). Subsequent studies demonstrated that several IAPs exist and function by binding to the inactive pro-caspase, therefore, inhibiting its processing to the active form (Hay et al, 1994;Hay et al, 1995;Hay, 2000).…”